ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh.

ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division. This potent medication is specifically designed to target and treat serious infections caused by multidrug-resistant gram-negative bacteria, a major concern in healthcare today. The launch event was marked by a comprehensive Training Session for our […]

ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh. Read More »

ZAS Corporation Ltd. Commits to Advancing Neonatal Care at the 4th International Scientific Conference of Bangladesh Perinatal Society

ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication to enhancing neonatal care worldwide. With a firm commitment to the health and well-being of mothers and newborns, ZAS joins forces with esteemed global experts to champion this critical cause. Through collaborative efforts and innovative

ZAS Corporation Ltd. Commits to Advancing Neonatal Care at the 4th International Scientific Conference of Bangladesh Perinatal Society Read More »

Bangladesh Endocrine Society and ZAS Corporation Collaborate to Advance Gonadal Hormone Replacement Therapy Knowledge.

In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical experts to conduct a Continuing Medical Education (CME) session delving into the current perspective of Gonadal Hormone Replacement Therapy (GHRT). This significant initiative aimed to enhance understanding and practice in the realm of endocrine health, ultimately striving for improved patient care across

Bangladesh Endocrine Society and ZAS Corporation Collaborate to Advance Gonadal Hormone Replacement Therapy Knowledge. Read More »

ZAS Corporation Ltd. and Bangladesh Lung Foundation Host Scientific Seminar on RTI Prevention

In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with the Bangladesh Lung Foundation to pioneer a groundbreaking Scientific Seminar on Recurrent Respiratory Tract Infection (RTI) Prevention. Held in a collaborative effort to explore the potential of Lyophilized Bacterial Lysates, the seminar illuminated innovative pathways for effective healthcare solutions.

ZAS Corporation Ltd. and Bangladesh Lung Foundation Host Scientific Seminar on RTI Prevention Read More »

Morinaga Research Centre and Bangladeshi KOL Doctors Forge Path to a ‘Forever Brighter Smile’ in Healthcare Innovation.

Morinaga Research Centre, Japan, joins hands with esteemed KOL Doctors from Bangladesh to pioneer groundbreaking collaborations, aimed at revolutionizing healthcare for a ‘Forever Brighter Smile’. Together, they envision a future where innovative solutions enhance oral health in Bangladesh and beyond. This strategic alliance promises to bring forth transformative advancements, setting new benchmarks in dental care.

Morinaga Research Centre and Bangladeshi KOL Doctors Forge Path to a ‘Forever Brighter Smile’ in Healthcare Innovation. Read More »

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session

In a momentous gathering at ZAS, divisional heads came together for an inspiring ‘Towards Tomorrow – A Collective Visioning Session.’ Led by the Chairman and Managing Director, alongside visionary leaders, the event marked a pivotal occasion as the course for future goals was charted. With a shared vision to redefine success and innovation, the leaders

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session Read More »

ZAS Critical Care Charts Path ‘Towards Growth’ in Successful Annual Strategic Meeting

ZAS Corporation’s esteemed sales division, Zas Critical Care, recently concluded its annual strategic meeting with a resounding success under the theme “Towards Growth.” The gathering was graced by the presence of Zas Corporation’s top executives, including the General Manager and CEO. The meeting showcased the division’s commitment to advancing critical healthcare solutions, aligning with the

ZAS Critical Care Charts Path ‘Towards Growth’ in Successful Annual Strategic Meeting Read More »

A successful conclusion of CPHI Barcelona & the start of exciting new opportunities!

The conclusion of CPHI Barcelona signifies not just the end of an event but the dawn of exciting new opportunities for ZAS. This milestone marks the commencement of a journey filled with intensive networking and productivity, solidifying powerful connections with industry innovators. With an expanded global network as a foundation, ZAS is now strategically positioned

A successful conclusion of CPHI Barcelona & the start of exciting new opportunities! Read More »

ZAS Revolutionizes Respiratory Health with Groundbreaking Scientific Session.

ZAS marked a historic milestone by hosting the inaugural Scientific Session at Hotel Radisson Blu Dhaka, focusing on the preventive potential of Lyophilized Bacterial Lysates for Recurrent Respiratory Tract Infections. The event showcased the newly launched Broncho-Vaxom, a revolutionary lyophilized bacterial lysate with a precise 7mg dosage. Attended by distinguished ICU, Respiratory Medicine, Pediatrician, and

ZAS Revolutionizes Respiratory Health with Groundbreaking Scientific Session. Read More »

Scroll to Top